Cargando…
Role of lipid-lowering agents in the management of diabetic retinopathy
Diabetic retinopathy affects a substantial proportion of patients with diabetes mellitus (DM) and is the leading cause of blindness in working-aged adults. Even though the incidence of diabetic retinopathy has declined in the last decades, its prevalence increased and is expected to rise further as...
Autores principales: | Ioannidou, Estelle, Tseriotis, Vasilis-Spyridon, Tziomalos, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237812/ https://www.ncbi.nlm.nih.gov/pubmed/28138358 http://dx.doi.org/10.4239/wjd.v8.i1.1 |
Ejemplares similares
-
Is there a role for glucagon-like peptide-1 receptor agonists in the management of diabetic nephropathy?
por: Veneti, Stavroula, et al.
Publicado: (2020) -
Role of sodium-glucose co-transporter-2 inhibitors in the management of heart failure in patients with diabetes mellitus
por: Alkagiet, Stelina, et al.
Publicado: (2020) -
The Role of Lipid-Lowering Treatment in the Secondary Prevention of Ischemic Stroke
por: Tsankof, Alexandra, et al.
Publicado: (2021) -
Effects of glucose-lowering agents on ischemic stroke
por: Avgerinos, Konstantinos, et al.
Publicado: (2017) -
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
por: Neokosmidis, Georgios, et al.
Publicado: (2018)